NAFLD in HIV-infected Patients

  • STATUS
    Recruiting
  • participants needed
    400
  • sponsor
    Shanghai Public Health Clinical Center
Send
Updated on 16 February 2024
See if I qualify
liver disease
fatty liver

Summary

The prevalence of NAFLD (nonalcoholic fatty liver disease) in HIV-infected patients is higher than that in general population, but the causes of morbidity and pathogenesis have not been fully explored. The investigators are planning to consecutively enroll 400 cases HIV-positive outpatients, and to detect NAFLD by ultrasound. The fecal and blood samples were also collected to explore the mechanism of NAFLD. The investigators aimed to determine the prevalence and risk factors of NAFLD in HIV infected patients.

Details
Condition NAFLD, HIV-infection/Aids
Age 18years - 70years
Treatment No intervention; cross-sectional study
Clinical Study IdentifierNCT04215926
SponsorShanghai Public Health Clinical Center
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Age 18~70 y
HIV-positive patients
written the informed consent

Exclusion Criteria

coinfected with HBV, HCV
secondary causes of fatty liver (eg, consumption of amiodarone and tamoxifen) and decompensated liver disease
significant alcohol consumption (>20 g per day for man, >10 g per day for woman)
received antibiotics in preceding two months
autoimmune disease
severe heart, lung, kidney, brain, blood diseases or other important systemic diseases
pregnant or lactating women
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

liver disease
fatty liver

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.